WASHINGTON — The Holland Foundation for Sight Restoration is dedicated to treating patients with severe ocular surface disease with stem cell deficiency.According to Edward J. Holland, MD, the foundation’s cofounder, less than 1% of patients diagnosed with the condition receive treatment, making it one of the largest areas of unmet need in ophthalmology. To address this gap, the foundation created a treatment protocol: The Cincinnati Protocol.{{VIDEO}}“We’ve shown that we have very safe treatment options with ocular surface stem cell transplantation and systemic image suppression,” he told
